Blood Culture Contamination and Diagnostic Stewardship: From a Clinical Laboratory Quality Monitor to a National Patient Safety Measure
The Journal of Applied Laboratory Medicine · 03.01.2025 · 10 (1) · 162-170
DOI: 10.1093/jalm/jfae132 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 03.01.2025. Verfasst von Jake D Bunn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention (CDC), Office of Laboratory Systems and Response (OLSR), Divsion of Laboratory Systems (DLS), Atlanta, GA,…. Hauptthemen laut MEDLINE: Blood Culture, Patient Safety. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Themen: Patientensicherheit
Abstract (Originalsprache)
Laboratory analysis of blood cultures is vital to the accurate and timely diagnosis of bloodstream infections. However, the reliability of the test depends on clinical compliance with standard operating procedures that limit the risk of inconclusive or incorrect results. False-negative blood culture results due to inadequate volumes of blood can result in misdiagnosis, delay therapy, and increase patients’ risk of developing or dying from bloodstream infections. Likewise, commonly occurring bacteria or fungi on human skin (i.e., commensal organisms) can contaminate the blood culture during collection and increase the risk of false positives, compromising care and leading to unnecessary antibiotic therapy and prolonged hospitalization. In December 2022, a Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE) endorsed the Centers for Disease Control and Prevention’s (CDC) proposal for a new patient safety measure to address these concerns. CDC developed this quality measure to promote the standardization of blood culture best practices and improve laboratory diagnosis of bloodstream infections nationally. This special report will emphasize the importance of standardizing blood culture collection and describe the need for a national patient safety measure, new quality tools, and next steps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centers for Disease Control and Prevention (CDC), Office of Laboratory Systems and Response (OLSR), Divsion of Laboratory Systems (DLS), Atlanta, GA, United States.
ORCID-Profile: Jake D Bunn
Förderung
- Intramural CDC HHS
Zitieren
APA
Bunn, J. D., & Cornish, N. E. (2025). Blood Culture Contamination and Diagnostic Stewardship: From a Clinical Laboratory Quality Monitor to a National Patient Safety Measure. The Journal of Applied Laboratory Medicine, 10(1), 162-170. https://doi.org/10.1093/jalm/jfae132
Vancouver
Bunn JD, Cornish NE. Blood Culture Contamination and Diagnostic Stewardship: From a Clinical Laboratory Quality Monitor to a National Patient Safety Measure. The Journal of Applied Laboratory Medicine. 2025;10(1):162-170. doi:10.1093/jalm/jfae132
BibTeX
@article{Bunn2025,
author = {Bunn, Jake D and Cornish, Nancy E},
title = {Blood Culture Contamination and Diagnostic Stewardship: From a Clinical Laboratory Quality Monitor to a National Patient Safety Measure},
journal = {The Journal of Applied Laboratory Medicine},
year = {2025},
volume = {10},
number = {1},
pages = {162--170},
doi = {10.1093/jalm/jfae132}
}
EUVIMED